Phil B.FontanarosaMD, Interim CoeditorIndividualAuthorMargaret A.WinkerMD, Deputy EditorIndividualAuthorStephenLurieMD PhD, Fishbein FellowIndividualAuthor
To the Editor: Although the study by Dr Izaks
and colleagues1 on the definition of anemia
in older persons provides valuable information, several key points require
First, all the statistically significant mortality data presented are
for the 0- to 5-year follow-up period. For the remaining 5- to 10-year follow-up
period, however, there is no difference in mortality between anemic and normocythemic
patients. In fact, in patients without apparent clinical disease, there is
a trend toward a decreased risk of death in anemic patients. Can the authors
explain this? In addition, was the difference in the mortality rate between
anemic and normocythemic patients statistically significant?
Hassaballa H. Anemia in Older Patients. JAMA. 1999;282(21):2001. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-21-jbk1201
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: